GTG — Genetic Technologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Genetic Technologies, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	11.7	7.85	1.02	0.01	0.01
Net Total Accounts Receivable
Net Total Receivables	2.42	1.92	2.13	0	0.017
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	14.7	10.5	3.7	0.01	0.038
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.953	0.599	0.264	0	—
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	20.8	14.9	6.19	0.01	0.038
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.81	3.31	4.2	0	0.457
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	4.37	3.69	4.36	0	0.457
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	16.4	11.2	1.83	0.01	-0.419
Total Liabilities & Shareholders' Equity	20.8	14.9	6.19	0.01	0.038
Total Common Shares Outstanding